Filed: 2/14/2025ACC: 0000950123-25-002377
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $267.37M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
20
Positions
$267.37M
Total AUM (reported)
21.94M
Total Shares
Allocation by class
SHS$147.64M55.2%
COM$66.14M24.7%
COM NEW$32.38M12.1%
COM PAR $.01$21.21M7.9%
Portfolio Concentration
Top 3$190.72M71.3%
4–10$49.37M18.5%
11–25$27.28M10.2%
Top 3 weight
71.3%
Top 10 weight
89.8%
Voting Authority Distribution
Total shares with voting rights: 21.94M
Sole
Full voting authority
21.94M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole20
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings20
Rows:
ROIVANT SCIENCES LTD
SOLEShares12.48M
TypeSH
Market value$147.64M
55.22%
Sole
12.48M
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares1.86M
TypeSH
Market value$21.88M
8.18%
Sole
1.86M
Shared
0.00
None
0.00
INSMED INC
SOLEShares307.17K
TypeSH
Market value$21.21M
7.93%
Sole
307.17K
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares878.90K
TypeSH
Market value$10.70M
4.00%
Sole
878.90K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS
SOLEShares1.41M
TypeSH
Market value$10.51M
3.93%
Sole
1.41M
Shared
0.00
None
0.00
NURIX THERAPEUTICS, INC.
SOLEShares446.30K
TypeSH
Market value$8.41M
3.14%
Sole
446.30K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC.
SOLEShares71.99K
TypeSH
Market value$6.01M
2.25%
Sole
71.99K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares224.04K
TypeSH
Market value$5.04M
1.89%
Sole
224.04K
Shared
0.00
None
0.00
GERON CORPORATION
SOLEShares1.32M
TypeSH
Market value$4.68M
1.75%
Sole
1.32M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX, INC.
SOLEShares470.92K
TypeSH
Market value$4.02M
1.50%
Sole
470.92K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS, INC.
SOLEShares121.73K
TypeSH
Market value$4.00M
1.50%
Sole
121.73K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares207.60K
TypeSH
Market value$3.98M
1.49%
Sole
207.60K
Shared
0.00
None
0.00
DISC MEDICINE, INC.
SOLEShares56.40K
TypeSH
Market value$3.58M
1.34%
Sole
56.40K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS, INC.
SOLEShares93.14K
TypeSH
Market value$3.37M
1.26%
Sole
93.14K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS, INC.
SOLEShares1.49M
TypeSH
Market value$3.17M
1.19%
Sole
1.49M
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS, INC.
SOLEShares64.90K
TypeSH
Market value$2.68M
1.00%
Sole
64.90K
Shared
0.00
None
0.00
INTELLIA THERAPEUTICS, INC.
SOLEShares215.98K
TypeSH
Market value$2.52M
0.94%
Sole
215.98K
Shared
0.00
None
0.00
ARVINAS, INC.
SOLEShares86.63K
TypeSH
Market value$1.66M
0.62%
Sole
86.63K
Shared
0.00
None
0.00
SCHOLAR ROCK HOLDING CORPORATION
SOLEShares32K
TypeSH
Market value$1.38M
0.52%
Sole
32K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares105.06K
TypeSH
Market value$939.2K
0.35%
Sole
105.06K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 12.48M | SH | $147.64M 55.22% | 12.48M | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 1.86M | SH | $21.88M 8.18% | 1.86M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 307.17K | SH | $21.21M 7.93% | 307.17K | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 878.90K | SH | $10.70M 4.00% | 878.90K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALSSOLE | COM NEW | 1.41M | SH | $10.51M 3.93% | 1.41M | 0.00 | 0.00 |
NURIX THERAPEUTICS, INC.SOLE | COM | 446.30K | SH | $8.41M 3.14% | 446.30K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INC.SOLE | COM | 71.99K | SH | $6.01M 2.25% | 71.99K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 224.04K | SH | $5.04M 1.89% | 224.04K | 0.00 | 0.00 |
GERON CORPORATIONSOLE | COM | 1.32M | SH | $4.68M 1.75% | 1.32M | 0.00 | 0.00 |
OCULAR THERAPEUTIX, INC.SOLE | COM | 470.92K | SH | $4.02M 1.50% | 470.92K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS, INC.SOLE | COM | 121.73K | SH | $4.00M 1.50% | 121.73K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 207.60K | SH | $3.98M 1.49% | 207.60K | 0.00 | 0.00 |
DISC MEDICINE, INC.SOLE | COM | 56.40K | SH | $3.58M 1.34% | 56.40K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS, INC.SOLE | COM | 93.14K | SH | $3.37M 1.26% | 93.14K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS, INC.SOLE | COM | 1.49M | SH | $3.17M 1.19% | 1.49M | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS, INC.SOLE | COM | 64.90K | SH | $2.68M 1.00% | 64.90K | 0.00 | 0.00 |
INTELLIA THERAPEUTICS, INC.SOLE | COM | 215.98K | SH | $2.52M 0.94% | 215.98K | 0.00 | 0.00 |
ARVINAS, INC.SOLE | COM | 86.63K | SH | $1.66M 0.62% | 86.63K | 0.00 | 0.00 |
SCHOLAR ROCK HOLDING CORPORATIONSOLE | COM | 32K | SH | $1.38M 0.52% | 32K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 105.06K | SH | $939.2K 0.35% | 105.06K | 0.00 | 0.00 |